Brief: BioVaxys Expands Intellectual Property Portfolio
24/03/2021 12:11
March 24 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS - FILING OF AN INTERNATIONAL PATENT APPLICATION
FOR
HAPTENIZED VIRAL ANTIGEN VACCINE PLATFORM
* BIOVAXYS - FILING OF AN INTERNATIONAL PATENT APPLICATION
FOR
NEW CLAIMS FOR A MULTIVALENT VERSION OF ITS SARS-COV-2 VACCINE
CANDIDATE
Source text for Eikon: ID:nPrew3Xrja
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000